Evidence map›Paper›PMID 42610700›Full record

ArticlemSystems2026

Transcriptional regulation drives heteroresistance in

Weijie Feng, Jia Hou, Gang Li, He Yin, Tiantian Dang, Guangqi Li, Jiaming Li, Min Li, Chunhua Song, Sean X Leng and 1 more

Abstract read
In one paragraph

Article in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Weijie Feng *General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.ORCID 0009-0000-0035-5723
Jia Hou *Department of Respiratory and Critical Care Medicine, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Gang LiMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
He YinMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Tiantian DangMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Guangqi LiMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Jiaming LiMedical Laboratory Center, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
Min LiCentral Laboratory, Peking University First Hospital Ningxia Women and Children's Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital), Yinchuan, Ningxia, China.
Chunhua SongDivision of Hematology, The Ohio State University Wexner Medical Center, The James Cancer Hospital, Columbus, Ohio, USA.ORCID 0000-0002-4081-2543
Sean X LengJohns Hopkins Center on Aging and Immune Remodeling, Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine and Bloomberg School of Public Health, Baltimore, Maryland, USA.ORCID 0000-0002-2690-8055
Zhijun ZhaoCentral Laboratory, Peking University First Hospital Ningxia Women and Children's Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital), Yinchuan, Ningxia, China.ORCID 0000-0002-8044-6648

Funding

Milstein Medical Asian American Partnership FoundationNatural Science Foundation of Ningxia Province 2024AAC03696Science and Technology Department of Ningxia Province 2024FRD05043
6 · The paper itself

Abstract

Bacterial heteroresistance, characterized by the presence of antibiotic-resistant subpopulations within phenotypically susceptible bacterial colonies, poses significant challenges to clinical antimicrobial susceptibility testing and treatment outcomes. While heteroresistance has been increasingly recognized across diverse bacterial species, the underlying mechanisms in

Indexed as

Drug Resistance, BacterialGene Expression Regulation, BacterialPseudomonas aeruginosaAnti-Bacterial AgentsBacterial ProteinsGene Expression ProfilingGenomicsHumansMicrobial Sensitivity TestsPseudomonas InfectionsAnti-Bacterial AgentsBacterial ProteinsheteroresistancePseudomonas aeruginosaresistance mechanismstranscriptional regulationtwo-component system

Identifiers

PMID42610700
PMCPMC13595920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.